DrCarney.com Blog
Artificial sweeteners and risk of incident cardiovascular disease and mortality: evidence from UK Biobank
Lovers of artificial sweeteners may be highly prone to suffer from different cardiovascular diseases, including heart failure (HF), coronary artery disease (CAD), and peripheral arterial disease (PAD).
This study clarified the association between high dietary exposure to artificial sweeteners and cardiovascular disease development and mortality risk. Researchers compared dietary choices with cardiovascular disease diagnosis rates among 133,285 UK men and women.
Researchers noticed that participants at the top of the artificial sweetener consumption ladder had the greatest risk of developing different cardiovascular ailments, including heart failure (HF), coronary artery disease (CAD), and peripheral arterial disease (PAD). The results of this study suggest that fondness for artificial sweeteners may increase an individual's susceptibility to cardiovascular disease.
Research Summary Information
-
2024
-
Tao Sun, Juan Yang, Fang Lei, Xuewei Huang, Weifang Liu, Xingyuan Zhang, Lijin Lin, Linsu Sun, Xinlan Xie, Xiao-Jing Zhang, Jingjing Cai, Zhi-Gang She, Chengsheng Xu, Hongliang Li
-
Department of Cardiology, Renmin Hospital of Wuhan University, 99 Zhangzhidong Rd, 430060, Wuhan, China. Institute of Model Animal, Wuhan University, Wuhan, China. Department of Cardiology, Huanggang Central Hospital of Yangtze University, Huanggang, China. State Key Laboratory of New Drug Discovery and Development for Major Diseases, Gannan Medical University, Ganzhou, China. Gannan Innovation and Translational Medicine Research Institute, Gannan Medical University, Ganzhou, China. Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China. Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China. School of Basic Medical Science, Wuhan University, Wuhan, China. Department of Cardiology, Renmin Hospital of Wuhan University, 99 Zhangzhidong Rd, 430060, Wuhan, China. zgshe@whu.edu.cn. State Key Laboratory of New Drug Discovery and Development for Major Diseases, Gannan Medical University, Ganzhou, China. zgshe@whu.edu.cn. Gannan Innovation and Translational Medicine Research Institute, Gannan Medical University, Ganzhou, China. zgshe@whu.edu.cn. Institute of Model Animal, Wuhan University, Wuhan, China. zgshe@whu.edu.cn. Department of Cardiology, Huanggang Central Hospital of Yangtze University, Huanggang, China. 735875160@qq.com. Department of Cardiology, Renmin Hospital of Wuhan University, 99 Zhangzhidong Rd, 430060, Wuhan, China. lihl@whu.edu.cn. State Key Laboratory of New Drug Discovery and Development for Major Diseases, Gannan Medical University, Ganzhou, China. lihl@whu.edu.cn. Gannan Innovation and Translational Medicine Research Institute, Gannan Medical University, Ganzhou, China. lihl@whu.edu.cn. Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China. lihl@whu.edu.cn.
-
Yes, Free full text of study was found:
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
About the author
